Literature DB >> 11291046

Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients.

H K Machulla1, L P Müller, A Schaaf, G Kujat, U Schönermarck, J Langner.   

Abstract

The etiology of chronic lymphocytic leukemia (CLL) remains unknown, though a genetic susceptibility has been suggested. Results of complete DNA typing of HLA alleles in CLL patients are lacking. We compared HLA class I and class II frequencies in 101 German CLL patients and 157 healthy German controls as determined by PCR-SSP/SSO DNA analysis and serologic typing. The most striking difference was the increased frequency of HLA-DRB4*0103 [relative risk (RR) = 2.74, p < 0.0025] among patients. The presence of alleles HLA-DRB1*0401, HLA-DQB1*0302 and HLA-DPB1*0301 as well as of homozygosity for HLA-DQB1 was also associated with a higher risk for CLL, though none of these differences remained significant after correction for multiple comparisons. No association was found for any HLA class I allele. Haplotype analysis revealed a CLL-specific linkage disequilibrium for HLA-DRB1*0401:DRB4*0103 and HLA-DRB4*0103:DQB1*0302. Our results suggest that CLL could be associated with distinct class II alleles of the Caucasian haplotype HLA-DR4:DR53:DQ8, which has also been related to a susceptibility for several auto-immune diseases. The positive, though weak, association of CLL with HLA-DPB1*0301 might represent an independent susceptibility factor since no linkage disequilibrium existed with any of the other CLL-associated alleles. None of the previously reported associations with HLA class I antigens was confirmed. Our results suggest that factors within or close to the human MHC class II region confer susceptibility to CLL. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291046     DOI: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1167>3.0.co;2-a

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci.

Authors:  Gabrielle S Sellick; Emily L Webb; Ruth Allinson; Estella Matutes; Martin J S Dyer; Viggo Jonsson; Anton W Langerak; Francesca R Mauro; Stephen Fuller; James Wiley; Matthew Lyttelton; Vincenzo Callea; Martin Yuille; Daniel Catovsky; Richard S Houlston
Journal:  Am J Hum Genet       Date:  2005-08-02       Impact factor: 11.025

2.  Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL).

Authors:  Elias Orouji; Jalil Tavakkol Afshari; Zahra Badiee; Abbas Shirdel; Afrouz Alipour
Journal:  Int J Hematol       Date:  2012-03-21       Impact factor: 2.490

3.  Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.

Authors:  Evgeny Arons; Sharon Adams; David J Venzon; Ira Pastan; Robert J Kreitman
Journal:  Br J Haematol       Date:  2014-06-13       Impact factor: 6.998

Review 4.  Inherited predisposition to chronic lymphocytic leukemia.

Authors:  Jennifer R Brown
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

5.  Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders.

Authors:  Viggo Jønsson; Geir E Tjønnfjord; Tom B Johannesen; Sven Ove Samuelsen; Bernt Ly
Journal:  Transl Oncogenomics       Date:  2008-02-10

6.  HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.

Authors:  María García-Álvarez; Miguel Alcoceba; Miriam López-Parra; Noemí Puig; Alicia Antón; Ana Balanzategui; Isabel Prieto-Conde; Cristina Jiménez; María E Sarasquete; M Carmen Chillón; María Laura Gutiérrez; Rocío Corral; José María Alonso; José Antonio Queizán; Julia Vidán; Emilia Pardal; María Jesús Peñarrubia; José M Bastida; Ramón García-Sanz; Luis Marín; Marcos González
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

7.  Human leukocyte antigens-DRB1*03 is associated with systemic lupus erythematosus and anti-SSB production in South Tunisia.

Authors:  Hend Hachicha; Arwa Kammoun; Nadia Mahfoudh; Sameh Marzouk; Sawsan Feki; Raouia Fakhfakh; Hajer Fourati; Samy Haddouk; Faten Frikha; Lilia Gaddour; Feiza Hakim; Zouheir Bahloul; Hafedh Makni; Hatem Masmoudi
Journal:  Int J Health Sci (Qassim)       Date:  2018 Jan-Feb

8.  A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.

Authors:  Gabrielle S Sellick; Lynn R Goldin; Ruth W Wild; Susan L Slager; Laura Ressenti; Sara S Strom; Martin J S Dyer; Francesca R Mauro; Gerald E Marti; Stephen Fuller; Matthew Lyttelton; Thomas J Kipps; Michael J Keating; Timothy G Call; Daniel Catovsky; Neil Caporaso; Richard S Houlston
Journal:  Blood       Date:  2007-08-08       Impact factor: 22.113

9.  RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.

Authors:  Stavroula Ntoufa; Marina Gerousi; Stamatia Laidou; Fotis Psomopoulos; Georgios Tsiolas; Theodoros Moysiadis; Nikos Papakonstantinou; Larry Mansouri; Achilles Anagnostopoulos; Niki Stavrogianni; Sarka Pospisilova; Karla Plevova; Antonios M Makris; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood Adv       Date:  2021-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.